N T Uvalieva
Biographic Data
| ID | 157018 |
|---|---|
| NAME | N T Uvalieva |
| GIVEN NAMES | N T |
| FAMILY NAME | Uvalieva |
| SIGNATURE | UVALIEVA N T |
| AFFILIATIONS | West Kazakhstan Marat Ospanov State Medical University |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 1 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2017 |
| H-INDEX | 1 |
Prevalence of Potentially Adverse Drug-Drug Interactions in Hospitals of West Kazakhstan
Consequences of medical drugs use have been a subject of scientific research, both in terms of long-term effect on the gene pool of populations and immediate effects on human health. Drug-drug interactions (DDI) is an important and still insufficiently recognized cause of medical errors and costs for the healthcare system. We have studied the prevalence and structure of DDI in hospitals of West Kazakhstan. We performed a retrospective analysis of…
Prevalence of Potentially Adverse Drug-Drug Interactions in Hospitals of West Kazakhstan
Consequences of medical drugs use have been a subject of scientific research, both in terms of long-term effect on the gene pool of populations and immediate effects on human health. Drug-drug interactions (DDI) is an important and still insufficiently recognized cause of medical errors and costs for the healthcare system. We have studied the prevalence and structure of DDI in hospitals of West Kazakhstan. We performed a retrospective analysis of…
Prevalence of Potentially Adverse Drug-Drug Interactions in Hospitals of West Kazakhstan
Consequences of medical drugs use have been a subject of scientific research, both in terms of long-term effect on the gene pool of populations and immediate effects on human health. Drug-drug interactions (DDI) is an important and still insufficiently recognized cause of medical errors and costs for the healthcare system. We have studied the prevalence and structure of DDI in hospitals of West Kazakhstan. We performed a retrospective analysis of…
Adverse effect (1 work) · Confidence interval (1 work) · Drug (1 work) · Emergency Medicine (1 work) · Internal Medicine (1 work) · Medical prescription (1 work) · Medicine (1 work) · Odds ratio (1 work) · Pharmaceutical Practices and Patient Outcomes (1 work) · Pharmaceutical studies and practices (1 work)